AVE 33.3% 0.2¢ avecho biotechnology limited

18000 doses a day in anz, page-23

  1. 224 Posts.
    lightbulb Created with Sketch. 4
    I found this statement interesting from the website:

    Mastitis Management Australia (MMA) was founded as a collaborative Research and Development project and vehicle to test the relationship of a patented delivery technology utilising Tocopheryl Phosphates (known as TPM?), developed by an internationally emerging Melbourne biotech company, Phosphagenics Limited. Along with naturally occurring Beta-Carotene for use in the Dairy industry.

    http://mastitis-management-australia.com/

    JMMC

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $2.565K 874.4K

Buyers (Bids)

No. Vol. Price($)
29 40547400 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 39021116 27
View Market Depth
Last trade - 15.59pm 12/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.